PBYI
Puma Biotechnology, Inc.
9.80$
-0.5%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -1.5% | +7.6% | -90.9% | +974.8% | +41.4% | -76.9% | +289.9% | -31.2% | +48.8% | +6.9% | -89.5% | – | |
| – | +0.5% | +0.3% | +0.4% | -1.0% | -1.3% | -1.6% | -1.2% | -1.5% | -2.4% | -2.7% | -2.6% | – | |
| – | -4.4% | -2.3% | -13.3% | -0.4% | -14.7% | +15.6% | -19.6% | +2.8% | -3.3% | +17.3% | +3.0% | – | |
| – | – | – | -92.8% | -1,941.7% | – | – | – | -179.6% | – | – | +10.5% | – | |
| – | +66.7% | -100.0% | – | +0.0% | -20.0% | +281.3% | -67.2% | +30.0% | +38.5% | -100.0% | – | – | |
| – | -173.1% | +133.5% | – | -63.2% | -995.8% | – | -834.7% | – | -5,431.4% | – | +222.2% | – | |
| – | – | – | – | – | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.1% | – | |
| – | – | – | – | -1.3% | +1.3% | +0.0% | -1.1% | +1.2% | +0.0% | -0.3% | +0.4% | – | |
| – | -89.5% | -442.8% | – | – | +1,615.8% | -416.4% | – | – | – | – | -126.6% | – | |
| – | -1.7% | +8.0% | -91.0% | +994.1% | +41.5% | -77.2% | +296.0% | -31.3% | +49.6% | +6.6% | -89.5% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.